When Felix Barber peered through a laser-equipped microscope at living Bacillus subtilis cells, he witnessed something that had puzzled biologists for decades: the moment teichoic acids vanished from a bacterium's surface, the rod-shaped cell collapsed into an amorphous blob. But this wasn't just another microscopy curiosity—it was the key to understanding how bacteria maintain their form and, potentially, how to outmaneuver antibiotic resistance.
The discovery, published in Nature Microbiology, reveals a elegant molecular security system. Rod-shaped bacteria are Earth's most common bacterial form, and their rigid cell walls determine not just their appearance but how they grow, divide, and interact with their environment. For decades, researchers knew that removing wall teichoic acids—enigmatic molecules coating certain bacteria like B. subtilis—caused cells to lose their distinctive shape. What they didn't understand was the mechanism. Now, Barber and his team, led by senior author Enrique Rojas at NYU, have solved that mystery using a novel technique called "in situ biochemistry," which allowed them to perform chemistry on living cell surfaces while simultaneously watching the proteins that build the cell wall.
The mechanism they uncovered is surprisingly intricate. B. subtilis cells are constructed by two key components: peptidoglycan, a layer of sugars and amino acids synthesized by Rod complexes, and wall teichoic acids. The Rod complexes work methodically, reinforcing the cell wall along its circumference—essentially girdling the bacterium into a rod shape. But lurking in the wings is an enzyme called PBP1, which normally plays only a minor role, fixing mistakes made by the Rod complexes. When teichoic acids are present, they act as a restraint on PBP1, keeping it subdued. The moment teichoic acids disappear, the restraint vanishes. Rod complexes halt almost immediately, and PBP1 erupts into activity, synthesizing peptidoglycan in random directions instead of maintaining the orderly circumferential pattern. The result: the cell morphs into a shapeless blob.
But the mystery deepened when the researchers asked how teichoic acids controlled these proteins at a molecular level. Working with Ph.D. student Zarina Akbary, who developed an innovative method to measure cell wall porosity at nanometer resolution, the team discovered that nanometer-sized holes appeared within minutes of teichoic acid depletion. They found that PBP1, which was thought to repair damage in the cell wall, takes over from Rod complexes when those tiny pores suddenly expose the wall's interior. Remarkably, cells depleted of teichoic acids survive this transformation, growing slowly and stably in their blob state—they don't simply die.
The implications stretch far beyond basic biology. B. subtilis itself is a probiotic bacterium used to manufacture everything from natto, the Japanese fermented soybean delicacy, to antibiotics, hyaluronic acid for skincare products, and agricultural compounds that help plants fight disease. But the real significance lies in the therapeutic angle. By understanding how teichoic acids control bacterial shape, researchers have identified a potential strategy for overcoming antibiotic resistance: targeting wall teichoic acids themselves. "Understanding the factors that give rise to the shape of bacteria are important because those same factors are also what we want to inhibit with antibiotics," Barber said. This discovery opens a pathway to a new generation of medicines that could work where traditional antibiotics have begun to fail.